365 related articles for article (PubMed ID: 12917806)
1. Heterologous protein production and delivery systems for Lactococcus lactis.
Nouaille S; Ribeiro LA; Miyoshi A; Pontes D; Le Loir Y; Oliveira SC; Langella P; Azevedo V
Genet Mol Res; 2003 Mar; 2(1):102-11. PubMed ID: 12917806
[TBL] [Abstract][Full Text] [Related]
2. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems.
Pontes DS; de Azevedo MS; Chatel JM; Langella P; Azevedo V; Miyoshi A
Protein Expr Purif; 2011 Oct; 79(2):165-75. PubMed ID: 21704169
[TBL] [Abstract][Full Text] [Related]
3. [Progress on lactococcus lactis expressing heterologous antigens as live mucosal vaccines].
Shi D; Song Y; Li YJ
Wei Sheng Wu Xue Bao; 2006 Aug; 46(4):680-3. PubMed ID: 17037080
[TBL] [Abstract][Full Text] [Related]
4. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria.
van Roosmalen ML; Kanninga R; El Khattabi M; Neef J; Audouy S; Bosma T; Kuipers A; Post E; Steen A; Kok J; Buist G; Kuipers OP; Robillard G; Leenhouts K
Methods; 2006 Feb; 38(2):144-9. PubMed ID: 16414272
[TBL] [Abstract][Full Text] [Related]
5. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine.
Raha AR; Varma NR; Yusoff K; Ross E; Foo HL
Appl Microbiol Biotechnol; 2005 Jul; 68(1):75-81. PubMed ID: 15635459
[TBL] [Abstract][Full Text] [Related]
6. Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion.
Morello E; Bermúdez-Humarán LG; Llull D; Solé V; Miraglio N; Langella P; Poquet I
J Mol Microbiol Biotechnol; 2008; 14(1-3):48-58. PubMed ID: 17957110
[TBL] [Abstract][Full Text] [Related]
7. Live bacterial delivery systems for development of mucosal vaccines.
Thole JE; van Dalen PJ; Havenith CE; Pouwels PH; Seegers JF; Tielen FD; van der Zee MD; Zegers ND; Shaw M
Curr Opin Mol Ther; 2000 Feb; 2(1):94-9. PubMed ID: 11249657
[TBL] [Abstract][Full Text] [Related]
8. Dual inducible expression of recombinant GFP and targeted antisense RNA in Lactococcus lactis.
Oddone GM; Mills DA; Block DE
Plasmid; 2009 Sep; 62(2):108-18. PubMed ID: 19523486
[TBL] [Abstract][Full Text] [Related]
9. A xylose-inducible expression system for Lactococcus lactis.
Miyoshi A; Jamet E; Commissaire J; Renault P; Langella P; Azevedo V
FEMS Microbiol Lett; 2004 Oct; 239(2):205-12. PubMed ID: 15476967
[TBL] [Abstract][Full Text] [Related]
10. Optimization of fed-batch production of the model recombinant protein GFP in Lactococcus lactis.
Oddone GM; Lan CQ; Rawsthorne H; Mills DA; Block DE
Biotechnol Bioeng; 2007 Apr; 96(6):1127-38. PubMed ID: 17117427
[TBL] [Abstract][Full Text] [Related]
11. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice.
Jing H; Yong L; Haiyan L; Yanjun M; Yun X; Yu Z; Taiming L; Rongyue C; Liang J; Jie W; Li Z; Jingjing L
Vaccine; 2011 May; 29(24):4102-9. PubMed ID: 21497632
[TBL] [Abstract][Full Text] [Related]
13. A food-grade delivery system for Lactococcus lactis and evaluation of inducible gene expression.
Simões-Barbosa A; Abreu H; Silva Neto A; Gruss A; Langella P
Appl Microbiol Biotechnol; 2004 Jul; 65(1):61-7. PubMed ID: 14758518
[TBL] [Abstract][Full Text] [Related]
14. Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization.
Li HS; Piao DC; Jiang T; Bok JD; Cho CS; Lee YS; Kang SK; Choi YJ
Vaccine; 2015 Apr; 33(16):1959-67. PubMed ID: 25738814
[TBL] [Abstract][Full Text] [Related]
15. Expression of bioactive porcine interferon-gamma by recombinant Lactococcus lactis.
Rupa P; Monedero V; Wilkie BN
Vet Microbiol; 2008 May; 129(1-2):197-202. PubMed ID: 18164876
[TBL] [Abstract][Full Text] [Related]
16. Genome analysis of lactic acid bacteria in food fermentations and biotechnological applications.
Nga BH
Curr Opin Microbiol; 2005 Jun; 8(3):307-12. PubMed ID: 15939354
[TBL] [Abstract][Full Text] [Related]
17. Lactococcus lactis as a cell factory for delivery of therapeutic proteins.
Bahey-El-Din M; Gahan CG; Griffin BT
Curr Gene Ther; 2010 Feb; 10(1):34-45. PubMed ID: 20156189
[TBL] [Abstract][Full Text] [Related]
18. Current prophylactic and therapeutic uses of a recombinant Lactococcus lactis strain secreting biologically active interleukin-12.
Bermúdez-Humarán LG; Cortes-Perez NG; Ah-Leung S; Lefèvre F; Yang G; Pang Q; Wu C; Zeng Y; Adel-Patient K; Langella P
J Mol Microbiol Biotechnol; 2008; 14(1-3):80-9. PubMed ID: 17957114
[TBL] [Abstract][Full Text] [Related]
19. Lactococcus lactis: from the dairy industry to antigen and therapeutic protein delivery.
Bahey-El-Din M; Gahan CG
Discov Med; 2010 May; 9(48):455-61. PubMed ID: 20515614
[TBL] [Abstract][Full Text] [Related]
20. Heterologous protein expression by Lactococcus lactis.
Villatoro-Hernández J; Kuipers OP; Saucedo-Cárdenas O; Montes-de-Oca-Luna R
Methods Mol Biol; 2012; 824():155-65. PubMed ID: 22160898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
